Ecolab Acquires CID Lines from IK Investment Partners

Ecolab Acquires Bioquell

February 14, 2019

Medical Devices

Ecolab Inc. acquired 100% of Bioquell PLC for approximately £139 million (about $178 million), purchasing all outstanding shares and paying consideration to Bioquell shareholders. The acquisition brings Bioquell’s vaporized hydrogen peroxide bio-decontamination systems and services into Ecolab’s Life Sciences and healthcare offering to broaden its contamination-control and cleanroom capabilities globally.

Ecolab Acquires Barclay Water Management

November 1, 2024

Environmental Services

Ecolab has acquired Barclay Water Management, a Newton, Massachusetts-based provider of water safety and digital monitoring solutions, including the proprietary iChlor Monochloramine System. The acquisition (closed November 1, 2024) establishes a new growth platform integrated with Ecolab’s ECOLAB3D digital monitoring capabilities; Barclay reported approximately $50 million in sales for 2023.

Medline Acquires Ecolab's Surgical Solutions Business

August 1, 2024

Medical Devices

Medline has completed the acquisition of Ecolab Inc.'s global surgical solutions business, including the Microtek product lines. The deal transfers nearly 3,500 surgical solutions employees to Medline and expands Medline’s surgical product portfolio and service capabilities while Ecolab divests the business unit.

ICL Acquires Majority of Lavie Bio's Activities and Assets from Evogene

July 8, 2025

Biotechnology

ICL Group Ltd. has completed the acquisition of the majority of activities and assets of Lavie Bio Ltd., Evogene's ag-biologicals subsidiary, including Lavie Bio's BDD technology platform, microbial bank, pipeline and current commercial products. Evogene also transferred its MicroBoost AI tech-engine for agriculture to ICL as part of the divestiture; Lavie Bio core personnel will move to ICL while certain strategic partnerships remain with Lavie Bio.

IK Investment Partners to Acquire Majority Stake in Kersia from Ardian

October 12, 2020

Manufacturing

IK Investment Partners' IK IX Fund has entered exclusive negotiations and allocated CSR-linked financing to acquire a majority stake in Kersia from Ardian. Kersia is a global leader in biosecurity and food safety with revenues above €300m, operations in 120+ countries and more than 1,500 employees; IK intends to support the company's next stage of growth and sustainability agenda.

IK Investment Partners to Acquire Majority Stake in Innovad Group

February 17, 2021

Veterinary

IK Investment Partners' IX Fund has entered exclusive discussions to acquire a majority stake in Innovad Group from founder and CEO Jamal Al‑Saifi. The transaction — which includes Italian feed additives supplier Add‑Co Nutrition becoming a full subsidiary — will see co‑founder Ben Letor become CEO and reinvest alongside management; financial terms were not disclosed and closing is subject to regulatory approvals.